New Trial to Test Implantable Pacemaker for Serious Depression
(NEW YORK)Researchers at 20 leading medical centers in the US are testing a pacemaker-like device that may ease the symptoms of depression. Cyberonics, Inc., the device manufacturer, is currently awaiting approval form the Food and Drug Administration to begin clinical trials. The implanted device will stimulate a nerve that runs down the side of the neck. The nerve will be stimulated for 30 seconds, stop for 5 minutes, and begin again. Side effects of the stimulation include voice change, a sense that something is in the patient's mouth, and difficulty breathing during vigorous activity. For more information visit www.abcnews.com.
The CDC at a Crossroads: Budget Cuts, Public Health, and the Growing Threat of Infectious Diseases
March 12th 2025Budget cuts to the CDC threaten disease surveillance, outbreak response, and public health programs, increasing risks from measles, avian flu, and future pandemics while straining health care infrastructure nationwide.
Standing Up for Science: A Rally Participant’s Perspective
March 11th 2025Infection Control Today's Editorial Advisory Board member and contributing editor, Heather Stoltzfus, MPH, RN, CIC, recently joined the Stand Up for Science rally in Washington, DC. She gives a first-person perspective on the rally and the rally-goers' strong message.
